Markers of increased cardiovascular risk in patients with chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Markers of increased cardiovascular risk in patients with chronic kidney disease.

Markers of increased cardiovascular risk in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q34582124

about

Clinical SYNTAX Score - a good predictor for renal artery stenosis in acute myocardial infarction patients: analysis from the REN-ACS trial.The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases.The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease α-Iso-Cubebene Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation by Suppressing Osteopontin Expression.Ear lobe crease: a marker of coronary artery disease?Age influence on renalase and catecholamines concentration in hypertensive patients, including maintained dialysis.Heart function disturbances in chronic kidney disease - echocardiographic indices.MMP-2 and TIMP-2 in Patients with Heart Failure and Chronic Kidney Disease.

P2860

Q33904393-E0D34BFA-6E42-4954-9CC8-6D2F494BE594 Q33904413-CDDC6489-E80A-48C1-8A56-3E1C35A25D5E Q35693460-A7710EFC-F942-4DC3-9831-5B4CADCFCE43 Q36257613-E8EC9A40-5D4F-477C-AF25-911FDD2BC0F5 Q36418976-7A067306-FA44-4183-811A-CC37F0AAEFEE Q37391785-DFF838BA-54ED-4F1B-8DE3-E27F27052802 Q41952419-2C4BCA5C-3899-4536-BEFB-9E17A8A4A9E0 Q55233718-913187F5-F7F1-4A2F-8A8C-6FAB84923115

P2860

Markers of increased cardiovascular risk in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q34582124

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@ast

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@en

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@nl

type

label

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@ast

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@en

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@nl

prefLabel

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@ast

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@en

Markers of increased cardiovascular risk in patients with chronic kidney disease.

@nl

P1433

Q34582124-7DEBA9D2-DFA7-4358-87C1-B167A34E31AA

P1476

Q34582124-E32BCCC8-B7B5-4702-9CAF-B9E09C5C48E7

P2093

Q34582124-625AC528-9EB8-4F8D-8022-C60CF2F97A6B

Q34582124-F2A52FAD-9D73-43AB-951A-66580E94356A

Q34582124-FDD8EFAF-19DD-4E83-A0A7-1C937CB0CEF0

P2860

Q34582124-146CF0AE-4A95-4540-ABFE-FC80B422FAD4

Q34582124-153089CF-E635-4B6E-B5AC-1BD14CD5C382

Q34582124-153DB0B0-2C81-4A6B-904E-363052136D2B

Q34582124-155070D5-A823-4EE6-BB32-01E396698931

Q34582124-1633B86D-C31B-4503-A8C2-D58E99D2B52B

Q34582124-18819825-39EB-4306-87B2-53A09F52AF8D

Q34582124-21879CF8-E3E8-4D35-92D2-32D1174B64BA

Q34582124-2908D38B-3720-4EAC-BC14-13F506862731

Q34582124-32162881-B68E-4FC7-9C93-87860CFF7962

Q34582124-33194F59-4C97-4B58-87B3-EB2AAEA941C9

P2888

Q34582124-DD39C64F-50CC-4A18-B2DE-6B7565A25D44

P304

Q34582124-77995473-995D-4D44-8097-5A8AF05C9D5B

P31

Q34582124-E0C7B235-FF0F-42A8-BBC9-458637719E30

P356

Q34582124-635D3060-29E7-49B9-81BF-35C9DC3CFB6D

P478

Q34582124-303302C4-DA13-4E3B-AF5E-93AF527FE961

P50

Q34582124-5CC3D521-DDBE-4648-88B9-27CCE76EDE32

Q34582124-D57766FC-0AA5-43EA-8346-86E6CCC22089

Q34582124-F42C92F9-4BE2-44AA-B033-134A9A895902

P577

Q34582124-88CDE739-44FC-47C8-BB45-1520ADD0160F

P6179

Q34582124-0E791336-F87A-4F2A-9223-12F2A4622CA4

P698

Q34582124-798CB5FA-6B19-42F7-970E-F1D9B7D18BD3

P921

Q34582124-10DF28C4-3A51-4380-8092-2BDD3C0ABEBD

P932

Q34582124-824B21A8-495A-4DD3-B1E1-F1A0583C5DDD

P356

1476-511X-13-135

P1433

Lipids in Health and Disease

P1476

Markers of increased cardiovascular risk in patients with chronic kidney disease

@en

P2093

Beata Franczyk-Skóra

http://www.w3.org/2001/XMLSchema#string

Marek Nocuń

http://www.w3.org/2001/XMLSchema#string

Marta Michalska-Kasiczak

http://www.w3.org/2001/XMLSchema#string

P2860

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages

Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure.

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

Phosphate regulation of vascular smooth muscle cell calcification

Media calcification and intima calcification are distinct entities in chronic kidney disease

Renalase deficiency aggravates ischemic myocardial damage

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

P2888

1476-511x-13-135

P304

135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-511X-13-135

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Anna Gluba-Brzózka

P577

2014-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014805220

http://www.w3.org/2001/XMLSchema#string

P698

25145866

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

4246537

http://www.w3.org/2001/XMLSchema#string